Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
23 results
D1.291 - Hypertryptasemia and TPSAB1 allele β tryptase duplication, a case report
D1.292 - Assessing Quality of Life in Chronic Spontaneous Urticaria: Insights from DLQI Scores
D1.294 - Does food allergy test-guided dietary advice improve eczema control in children? Protocol for Trial of food allergy IgE tests for Eczema Relief (TIGER) study
D1.295 - Clinical, Laboratory and Prognostic Evaluation of Antinuclear Antibody Positive and Negative Children with Chronic Urticaria
D1.298 - Topical gluconolactone induces immune tolerance in cutaneous lupus erythematosus in human and mice
D1.300 - Alopecia areata associated with atopy has a distinct cytokine, chemokine and IgE profile
D1.303 - Preschooler with Toxic Epidermal Necrolysis Associated with Adenovirus Respiratory Infection
D1.304 - Occupational allergic contact dermatitis (Chronic hand eczema) to lily of the Incas and houseleek in a florist
D1.305 - Management of Contact Dermatitis in Pediatric Type 1 Diabetes: A Therapeutic Protocol with Topical Pimecrolimus
D1.306 - Is there a role of Genetics in Acute and Chronic Urticaria? A Systematic Review and Meta-analysis
D2.294 - Allergic contact dermatitis unit at Hospital Joan XXIII (Tarragona, Spain): descriptive analysis 2022 - 2023
D2.295 - Characterization of Treatment-Refractory Chronic Urticaria: A Large-Scale Retrospective Analysis of Clinical and Laboratory Parameters
D2.296 - Allergic contact dermatitis caused by a oxybutynin in a transdermal patch
D2.297 - SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria
D2.299 - A novel synthetic molecule LN49 suppressed oxidative stress and inflammation in skin epithelial and fibroblast cells via activating Nrf-2 signaling pathway
D2.300 - Fixed Drug Eruption related to the use of NSAIDs
D2.302 - Non - immediate hypersensitivity to oxybutynin, first confirmed case with lymphocyte transformation test
D2.303 - Blistering Discovery: A Rare Case of Toxic Epidermal Necrolysis Triggered by Carboplatin and Radiotherapy
D2.304 - Transepidermal Water Loss in Atopic Diseases
D2.305 - Acute generalized exanthematous pustulosis due to iohexol with tolerance to iobitridol
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download